-
1دورية أكاديمية
المؤلفون: Muthiah Vaikundaraja Indhuja, Sivasree Kesana, Nikita Mehra, Parathan Karunakaran, Arun Kumar Rajan, Venkatraman Radhakrishnan, Perumal Kalaiyarasi Jayachandran
المصدر: South Asian Journal of Cancer, Vol 13, Iss 02, Pp 121-125 (2024)
مصطلحات موضوعية: ALK+ ALCL, anaplastic large cell lymphoma, crizotinib in ALCL, ALK inhibitors in ALCL, relapsed refractory ALCL, targeted therapy in NHL, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Mingye Zhao, Taihang Shao, Hanqiao Shao, Caicun Zhou, Wenxi Tang
المصدر: BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)
مصطلحات موضوعية: ALK-inhibitors, Network meta-analysis, Non-small-cell lung cancer, Efficacy, Safety, Quality of life, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1471-2407Test
-
3دورية أكاديمية
المؤلفون: Michał Gil, Magdalena Knetki-Wróblewska, Przemysław Niziński, Maciej Strzemski, Paweł Krawczyk
المصدر: Annals of Medicine, Vol 55, Iss 1, Pp 1018-1028 (2023)
مصطلحات موضوعية: Non-small cell lung cancer, anaplastic lymphoma kinase, blood-brain barrier, ALK inhibitors, Medicine
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Ya-Kun Zhang, Jian-Bo Tong, Mu-Xuan Luo, Xiao-Yu Xing, Yu-Lu Yang, Zhi-Peng Qing, Ze-Lei Chang, Yan-Rong Zeng
المصدر: Arabian Journal of Chemistry, Vol 17, Iss 9, Pp 105863- (2024)
مصطلحات موضوعية: Tumor, QSAR, Artificial neural network, Piperidine carboxamide derivatives, ALK inhibitors, Chemistry, QD1-999
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S187853522400265XTest; https://doaj.org/toc/1878-5352Test
-
5دورية أكاديمية
المؤلفون: Ken Kodama, Toru Momozane, Kaichi Shigetsu, Hiroshi Takehara, Takamasa Toyofuku, Kinji Nishiyama, Genju Koh, Kiyoaki Uryu
المصدر: Clinical Case Reports, Vol 12, Iss 1, Pp n/a-n/a (2024)
مصطلحات موضوعية: ALK inhibitors, malignant psoas syndrome (MPS), non‐small cell lung cancer (NSCLC), pembrolizumab, radiation therapy, Medicine, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2050-0904Test
-
6دورية أكاديمية
المؤلفون: Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase, Kenji Chibana, Kyoichi Kaira, Kyoichi Okishio, Eiki Ichihara, Shuji Murakami, Mototsugu Shimokawa, Nobuyuki Yamamoto
مصطلحات موضوعية: Respiratory Diseases, Oncology and Carcinogenesis not elsewhere classified, Pharmacology and Pharmaceutical Sciences not elsewhere classified, Aged Health Care, alectinib, ALK inhibitors, brigatinib, non-small-cell lung cancer, observational study
الإتاحة: https://doi.org/10.25384/sage.25097209.v1Test
https://figshare.com/articles/journal_contribution/sj-docx-1-tam-10_1177_17588359231225046_Supplemental_material_for_Prospective_observational_study_to_explore_genes_and_proteins_predicting_efficacy_and_safety_of_brigatinib_for_ALK-gene_rearranged_non-small-cell_lung_cancer_study_protocol_f/25097209Test -
7دورية أكاديمية
المؤلفون: Juan Enrique Faya Castillo, Richard Junior Zapata Dongo, Paolo Alberto Wong Chero, Stefany Fiorella Infante Varillas
مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Cell Biology, Molecular Biology, Pharmacology, Biotechnology, Cancer, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, sup >+ sup, lung cancer associated, div >< p, different atomistic characteristics, deregulated catalytic domain, best interaction energies, based virtual screening, performed molecular docking, identified pharmacophores sites, different alk inhibitors, alk inhibitory characteristics, special literature proposed, proposed atomistic positions, used homology modelling, study proposes fda, identify potential ialks, aberrant protein kinase, approved drugs library, molecular dynamics, four pharmacophores
الإتاحة: https://doi.org/10.1371/journal.pone.0295966.s001Test
https://figshare.com/articles/journal_contribution/Supplementary_tables_/25153755Test -
8دورية أكاديمية
المؤلفون: Juan Enrique Faya Castillo, Richard Junior Zapata Dongo, Paolo Alberto Wong Chero, Stefany Fiorella Infante Varillas
مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Cell Biology, Molecular Biology, Pharmacology, Biotechnology, Cancer, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, sup >+ sup, lung cancer associated, div >< p, different atomistic characteristics, deregulated catalytic domain, best interaction energies, based virtual screening, performed molecular docking, identified pharmacophores sites, different alk inhibitors, alk inhibitory characteristics, special literature proposed, proposed atomistic positions, used homology modelling, study proposes fda, identify potential ialks, aberrant protein kinase, approved drugs library, molecular dynamics, four pharmacophores
الإتاحة: https://doi.org/10.1371/journal.pone.0295966.s002Test
https://figshare.com/articles/journal_contribution/Abbreviations_/25153758Test -
9دورية أكاديمية
المؤلفون: Mingye Zhao, Taihang Shao, Hanqiao Shao, Caicun Zhou, Wenxi Tang
مصطلحات موضوعية: Medicine, Pharmacology, Cancer, Science Policy, Mental Health, ALK-inhibitors, Network meta-analysis, Non-small-cell lung cancer, Efficacy, Safety, Quality of life
الإتاحة: https://doi.org/10.6084/m9.figshare.25194834.v1Test
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Identifying_optimal_ALK_inhibitors_in_first-_and_second-line_treatment_of_patients_with_advanced_ALK-positive_non-small-cell_lung_cancer_a_systematic_review_and_network_meta-analysis/25194834Test -
10دورية أكاديمية
المؤلفون: Bole Li, Shan Liu, Honglei Feng, Chunshuang Du, Liman Wei, Jie Zhang, Guangwei Jia, Chunnuan Wu
المصدر: Frontiers in Pharmacology, Vol 14 (2023)
مصطلحات موضوعية: ALK inhibitors, PBPK model, ALK occupancy, optimal dosing regimen, concentration prediction in cerebrospinal fluid, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2023.1234262/fullTest; https://doaj.org/toc/1663-9812Test